RecruitingPhase 1NCT07717918
A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants
A Phase 1B Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects
Sponsor
Bausch & Lomb Incorporated
Enrollment
28 participants
Start Date
Jul 6, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
Single center, double-masked study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called BL1332 Placebo eye drops and a drug called BL1332 eye drops for people with healthy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGBL1332 eye drops
Taken 1 time
DRUGBL1332 Placebo eye drops
Taken 1 time
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07717918
Related Trials
A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight
NCT076932313 locations
PET Imaging of Noradrenergic Transmission in the Brain
NCT076863931 location
Long-Term Effects of Walnut Consumption on Brain Function
NCT074222201 location
A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood
NCT076567921 location
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
NCT071696301 location